Literature DB >> 7528933

Chemotherapy for advanced non-small-cell lung cancer.

J Walling1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7528933     DOI： 10.1016/s0954-6111(05)80061-7

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  9 in total

1.  Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naïve advanced non-small-cell lung cancer in the era of third-generation agents.

Authors:  Jingwei Jiang; Xiaohua Liang; Xinli Zhou; Ruofan Huang; Zhaohui Chu; Qiong Zhan
Journal:  J Cancer Res Clin Oncol       Date:  2012-08-05       Impact factor: 4.553

2.  Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung Cancer.

Authors:  Catherine E Muehlenbein; J Russell Hoverman; Stephen K Gruschkus; Michael Forsyth; Clara Chen; William Lopez; Anthony Lawson; Heather J Hartnett; Gerhardt Pohl
Journal:  J Cancer Epidemiol       Date:  2011-05-02

3.  Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Authors:  Ming Li; Qian Zhang; Peifang Fu; Ping Li; Aimei Peng; Guoliang Zhang; Xiaolian Song; Min Tan; Xuan Li; Yang Liu; Yueping Wu; Suyun Fan; Changhui Wang
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

4.  A Case of Multifocal Skin Metastases from Lung Cancer Presenting with Vasculitic-type Cutaneous Nodule.

Authors:  Nalan Akgul Babacan; Saadettin Kiliçkap; Soner Sene; Turgut Kacan; Birsen Yucel; Mehmet Fuat Eren; Sener Cihan
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  Serum Protein Pattern Could Predict the Therapeutic Effect of First-Line Pemetrexed/Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma.

Authors:  Hong Shen; Xue-Feng Fang; Ying Yuan; Jiao Yang; Shu Zheng
Journal:  World J Oncol       Date:  2015-02-14

6.  Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.

Authors:  Serena Ricciardi; Silverio Tomao; Filippo de Marinis
Journal:  Ther Clin Risk Manag       Date:  2009-10-12       Impact factor: 2.423

7.  Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer.

Authors:  Francesca Russo; Alessandra Bearz; Gianni Pampaloni
Journal:  BMC Cancer       Date:  2008-07-31       Impact factor: 4.430

Review 8.  Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules.

Authors:  Xin Li; Sen Wei; Jun Chen
Journal:  Onco Targets Ther       Date:  2014-06-06       Impact factor: 4.147

Review 9.  Prophylactic cranial irradiation may impose a detrimental effect on overall survival of patients with nonsmall cell lung cancer: a systematic review and meta-analysis.

Authors:  Shuan-shuan Xie; Ming Li; Cai-cun Zhou; Xiao-lian Song; Chang-hui Wang
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.